Literature DB >> 23954238

3-Carboxy-pyrazolinalanine as a new scaffold for developing potent and selective NMDA receptor antagonists.

Lucia Tamborini1, Andrea Pinto, Federica Mastronardi, Maria C Iannuzzi, Gregorio Cullia, Birgitte Nielsen, Carlo De Micheli, Paola Conti.   

Abstract

A synthetic method for the preparation of suitably protected 3-carboxy-Δ2-pyrazolin-5-yl-alanine was developed. This scaffold is amenable to further decoration at the N1 position and was used to generate novel NMDA receptor ligands. Although weaker than the previously reported N1-Ph derivatives, the new ligands retain the ability to selectively bind to NMDA receptor with micromolar to submicromolar affinity. Considering the relevance of the N-functionalization for the biological activity, the results presented in this communication are preliminary to a full SAR study of this novel class of NMDA receptor antagonists.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Amino acid; Intramolecular cyclization; N-Methyl-d-aspartate receptor antagonist; Pyrazoline; l-Glutamic acid

Mesh:

Substances:

Year:  2013        PMID: 23954238     DOI: 10.1016/j.ejmech.2013.07.010

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  1 in total

1.  Development of Radiolabeled Ligands Targeting the Glutamate Binding Site of the N-Methyl-d-aspartate Receptor as Potential Imaging Agents for Brain.

Authors:  Lucia Tamborini; Ying Chen; Catherine A Foss; Andrea Pinto; Andrew G Horti; Stephen F Traynelis; Carlo De Micheli; Ronnie C Mease; Kasper B Hansen; Paola Conti; Martin G Pomper
Journal:  J Med Chem       Date:  2016-12-06       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.